0001127602-12-020259.txt : 20120618 0001127602-12-020259.hdr.sgml : 20120618 20120618165448 ACCESSION NUMBER: 0001127602-12-020259 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120618 FILED AS OF DATE: 20120618 DATE AS OF CHANGE: 20120618 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROTHBLATT MARTINE A CENTRAL INDEX KEY: 0001106578 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 12912924 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 4 1 form4.xml PRIMARY DOCUMENT X0305 4 2012-06-18 0001082554 UNITED THERAPEUTICS Corp UTHR 0001106578 ROTHBLATT MARTINE A C/O UNITED THERAPEUTICS CORPORATION 1040 SPRING STREET SILVER SPRING MD 20910 1 1 CEO Common Stock 2012-06-18 2012-06-18 4 P 0 4130 47.9964 A 682504 I By Trusts Common Stock 0 D This transaction was executed in multiple trades at prices ranging from $47.50 to $48.25. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Shares were purchased pursuant to a pre-arranged 10b5-1 trading plan entered into by a Grantor Retained Annuity Trust beneficially owned by the reporting person and the reporting person's spouse. Shares held by the reporting person in GRATs and PMTs. /s/ John S. Hess, Jr. under Power of Attorney 2012-06-18